In Vivo Models
Insulin/IGF-1 receptor signaling enhances biosynthetic activity and fat mobilization in the initialphase of starvation in adult male C. elegans.
Tan KT ; Luo SC ; Ho WZ ; Lee YH. Cell Metab. 2011 Sep 7;14(3):390-402.
CJ
Resources
Tan KT ; Luo SC ; Ho WZ ; Lee YH. Cell Metab. 2011 Sep 7;14(3):390-402.
Matsunaga Y ; Qadota H ; Furukawa M ; Choe HH ; Benian GM. Mol Biol Cell. 2015 Jun 1;26(11):2096-111.
Veriepe J ; Fossouo L ; Parker JA. Nat Commun. 2015 Jun 10;6:7319.
Matsunaga Y ; Hwang H ; Franke B ; Williams R ; Penley M ; Qadota H ; Yi H ; Morran LT ; Lu
Schmeisser K ; Fardghassemi Y; Parker JA. Exp Neurol. 2017 Jul;293:101-114.
Fardghassemi Y ; Tauffenberger A ; Gosselin S ; Parker JA. Dis Model Mech. 2017 Dec 19;10(12):1465-1480.
Luc Van Puyvelde; Maoxuan Liu; Cedrick Veryser; Wim M. De Borggraeve; Joseph Mungarulire; Marie Jeanne Mukazayire; Walter Luyten. J Ethnopharmacol. 2018 Apr 24;216:229-232.
Piper Reid Hunt; Nicholas Olejnik; Keenan D. Bailey; Cory A. Vaught; Robert L. Sprando. Food Chem Toxicol. 2018 Nov;121:583-592.
Risi G, Aguilera E, Ladós E, Suárez G, Carrera I, Álvarez G7, Salinas G. Vet Sci. 2019 Mar 17;6(1). pii: E29.
Rosenzvit MC et al. PLoS Negl Trop Dis. 2018 Feb; 12(2): e0006267.
Camicia F, Herz M, Prada LC, Kamenetzky L, Simonetta SH, Cucher MA, Bianchi JI, Fernández C, Brehm K, Rosenzvit MC. Int J Parasitol. 2013 Jul;43(8):647-59.
Liu M., Landuyt B., Klaassen H., Geldhof P., Luyten W. Veterinary Parasitology. 2018 Dec.
Liu M, Kipanga P, Mai AH, Dhondt I, Braeckman BP, De Borggraeve W, Luyten W. Int J Parasitol. 2018 Sep;48(11):833-844.
Steffen R. Hahnel, William M. Roberts, Iring Heisler, Daniel Kulke, Janis C. Weeks. International Journal for Parasitology: Drugs and Drug Resistance. Volume 16, August 2021,
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.